Previously, we have demonstrated that incorporation of apoprotein-B into liposome and acetylated LDL containing liposome carriers significantly enhance their uptake by Leishmania infected J774 macrophages via LDL and acetylated LDL receptors. To further enhance the potential of our drug delivery system, in the present investigation we have embarked upon characterization of the acetylated LDL containing liposome receptor-mediated endocytic pathways. The J774 model system was used to study the effect of a series of inhibitors and modulators of endocytosis including lysosomotropic agents and inhibitors of energy metabolism. Uptake of liposomes and acetylated LDL Liposomes were amplified significantly in the presence of lysosomotropic agents and considerably inhibited when cells were treated with azide, a metabolic inhibitor.